Noveris Health Sciences Announces Upcoming AGM and Record Date, and receipt of CSE Notice

Executive Summary

• Noveris Health Sciences Inc. has announced the date for its Annual General Meeting (AGM) of shareholders, scheduled for September 4, 2026.
• The company is under notice from the Canadian Securities Exchange (CSE) that it must demonstrate compliance with continued listing requirements by filing financial statements for the nine-month period ending September 30, 2026.
• Failure to meet these requirements by the specified deadline will result in the ".X" inactive designation being applied to the company's common shares.

Key Details

• AGM Details:
  • Date: September 4, 2026.
  • Time/Location: 1890-1075 West Georgia Street, Vancouver, British Columbia.
  • Record Date: July 21, 2026.
• AGM Agenda Items:
  • Election of directors for the ensuing year.
  • Appointment of the Company's auditor for the ensuing year and authorization of directors to fix the auditor's remuneration.
  • Any other proper business.
• Listing Compliance Warning:
  • The CSE has notified Noveris that it must demonstrate compliance with CSE Policy 3.5 (continued listing requirements).
  • The company will not conduct any investor relations activities until compliance is demonstrated.
  • Deadline: Financial statements for the nine-month period ending September 30, 2026, must be filed to demonstrate compliance.
  • Consequence: If compliance is not demonstrated by the filing deadline, the CSE will apply the ".X" inactive designation to the common shares.
• Management Action: Management is actively pursuing business plans and operations to meet listing requirements, referencing previous news releases from April and June 2026.

Notable Quotes

• "The Company also wishes to advise it is on notice it must demonstrate to the Canadian Securities Exchange (the “CSE”) that it is meeting continued listing requirements (as outlined in CSE Policy 3.5), and that it will not conduct any investor relations activities until such time."
• "If the Company is unable to demonstrate compliance with continued listing requirements by the time it files financial statements for its nine month period ending September 30, 2026, the CSE has informed the Company that the ".X" inactive designation will be applied to its common shares."